Literature DB >> 7055790

The prevalence of polyps of the large intestine in Oslo: an autopsy study.

M H Vatn, H Stalsberg.   

Abstract

The colon and rectum were removed from 445 consecutive autopsies and examined for the presence of polypoid lesions under an illuminating magnifying lens. There were seven clinically undiagnosed carcinomas, 329 adenomas, 174 hyperplastic polyps, 59 mucosal tags, 34 other polypoid lesions, and 54 polyps in which no histologic diagnosis could be made. Adenomas were present in 34% of the men and 32% of the women. The adenoma prevalence rate increased smoothly with age in men, whereas the rate in women showed a biphasic variation with a peak at 50--59 years followed by a second increase after 70 years of age. The distribution of adenomas within the bowel showed a marked change with age, from a moderate left-sided predominance before 60 years of age to a marked right-sided predominance in patients over 80 years of age, particularly in men. Hyperplastic polyps were present in 27% of the men and 18% of the women. In men, their frequency and distribution within the bowel showed similar changes with age as were seen for the adenomas. In women, no such age-dependency was observed for hyperplastic polyps. Multiplicity of polyps increased with age and was more pronounced in men than in women. Adenomas in women tended to be larger, more atypical, and more villous than in men. A comparison with a similar study from Northern Norway showed no difference in the prevalence of adenomas in spite of a 70% higher incidence rate for colorectal cancer in Oslo.

Entities:  

Mesh:

Year:  1982        PMID: 7055790     DOI: 10.1002/1097-0142(19820215)49:4<819::aid-cncr2820490435>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  97 in total

1.  [Conventional and molecular screening (fecal tests)].

Authors:  C Pox; K Schulmann; W Schmiegel
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

2.  Surveillance guidelines after removal of colorectal adenomatous polyps.

Authors:  W S Atkin; B P Saunders
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

3.  Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Authors:  Amy B Knudsen; Iris Lansdorp-Vogelaar; Carolyn M Rutter; James E Savarino; Marjolein van Ballegooijen; Karen M Kuntz; Ann G Zauber
Journal:  J Natl Cancer Inst       Date:  2010-07-27       Impact factor: 13.506

4.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

5.  Feasible economic strategies to improve screening compliance for colorectal cancer in Korea.

Authors:  Sang Min Park; Young Ho Yun; Soonman Kwon
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

6.  Flexible sigmoidoscopy for colorectal cancer screening in the elderly.

Authors:  Ajay Pabby; Anupam Suneja; Timothy Heeren; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

7.  Frailty modelling of colorectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort.

Authors:  Elisabeth Svensson; Tron A Moger; Steinar Tretli; Odd O Aalen; Tom Grotmol
Journal:  Eur J Epidemiol       Date:  2006-09-20       Impact factor: 8.082

8.  Polyps and diverticula of the large intestine: a necropsy survey in Hong Kong.

Authors:  P E Coode; K W Chan; Y T Chan
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

9.  Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber; J Dik F Habbema; Ernst J Kuipers
Journal:  J Natl Cancer Inst       Date:  2009-09-24       Impact factor: 13.506

10.  Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.

Authors:  Uri Ladabaum; Ajitha Mannalithara; Joel V Brill; Zachary Levin; Kate M Bundorf
Journal:  Am J Gastroenterol       Date:  2018-06-15       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.